NXPI vs VNDA · P/E 29, rev $12.27B vs rev $102.2M
NXP Semiconductors NV (NXPI) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the NXPI and VNDA stock pages for the full models.
Not investment advice.